Search

Biosynthesis of a ganoderic acid in Saccharomyces cerevisiae by expressing a cytochrome P450 gene from Ganoderma lucidum

메타 데이터

바이오화학분류
    • 바이오정밀화학
      1. 기타
    • 의료용 화학소재
      1. 건강보조식품
논문

Biosynthesis of a ganoderic acid in Saccharomyces cerevisiae by expressing a cytochrome P450 gene from Ganoderma lucidum

학술지

Biotechnology and bioengineering

저자명

Wang, Wen‐ Fang; Xiao, Han; Zhong, Jian‐ Jiang

초록

<P><B>Abstract</B></P><P>Ganoderic acid (GA), a triterpenoid from the traditional Chinese medicinal higher fungus <I>Ganoderma lucidum</I>, possesses antitumor and other significant pharmacological activities. Owing to the notorious difficulty and immaturity in genetic manipulation of higher fungi as well as their slow growth, biosynthesis of GAs in a heterologous host is an attractive alternative for their efficient bioproduction. In this study, using <I>Saccharomyces cerevisiae</I> as a host, we did a systematic screening of cytochrome P450 monooxygenase (CYP450) gene candidates from <I>G. lucidum</I>, which may be responsible for the GA biosynthesis from lanosterol but have not been functionally characterized. As a result, overexpression of a CYP450 gene <I>cyp5150l8</I> was firstly found to produce an antitumor GA, 3&#8208;hydroxy&#8208;lanosta&#8208;8, 24&#8208;dien&#8208;26 oic acid (HLDOA) in <I>S. cerevisiae</I>, as confirmed by HPLC, LC&#8208;MS and NMR. A final titer of 14.5 mg/L of HLDOA was obtained at 120 hr of the yeast fermentation. Furthermore, our in vitro enzymatic experiments indicate that CYP5150L8 catalyzes a three&#8208;step biotransformation of lanosterol at C&#8208;26 to synthesize HLDOA. To our knowledge, this is the first report on the heterologous biosynthesis of GAs. The results will be helpful to the GA biosynthetic pathway elucidation and to future optimization of heterologous cell factories for GA production.</P>

발행연도

2018

ISSN

0006-3592

ISSN

1097-0290

115

7

페이지

pp.1842-1854

주제어

cytochrome P450 monooxygenase (CYP450); medicinal mushroom; Saccharomyces cerevisiae; secondary metabolite biosynthesis; synthetic biology; triterpenoid

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

2건의 후보군 물질이 있습니다.

2 2023-12-11

논문; 2018-12-31

Export

About

Search

Trend